Escherichia coli as reservoir for macrolide resistance genes

Emerging Infectious Diseases

Volumn 15, Issue 10, 2009, Pages 1648-1650

  Nguyen, Minh Chau Phuc ^a   Woerther, Paul Louis ^b   Bouvet, Mathilde ^a   Andremont, Antoine ^b   Leclercq, Roland ^a,c   Canu, Annie ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; MACROLIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; MPH(A) GENE; MULTIDRUG RESISTANCE; NONHUMAN; SALMONELLA; SHIGELLA SONNEI;

DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; MACROLIDES; MICROBIAL SENSITIVITY TESTS;

EID: 70349974270     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1510.090696     Document Type: Article

References (12)

1. Gordillo ME, Singh KV, Murray B. In vitro activity of azithromycin against bacterial enteric pathogens. Antimicrob Agents Chemother. 1993;37:1203-1205
2. Centers for Disease Control and Prevention. Outbreaks of multidrug- resistant Shigella sonnei gastroenteritis associated with day care centers - Kansas, Kentucky, and Missouri, 2005. MMWR Morb Mortal Wkly Rep. 2006;55:1068-1071
3. World Health Organization. Guidelines for the control of shigellosis including epidemics due to Shigella dysenteriae type 1 [cited 23 Mar 2009]. Available from http://www.who.int/child-adolescent-health/ publications/ pubemergencies.htm
4. Effa EE, Bukirwa H. Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev. 2008;4:CD006083.
5. Boumghar-Bourtchai L, Mariani-Kurkdjian P, Bingen E, Filliol I, Dhalluin A, Ifrane SA, et al. Macrolide-resistant Shigella sonnei. Emerg Infect Dis. 2008;14:1297-1299 DOI: 10.3201/eid1408.080147
6. Ochiai K, Yamanaka T, Kimura K, Sawada 0. Studies on transfer of drug resistance between Shigella strains and Escherichia coli strains [in Japanese]. Nihon-ijishimpo No. 1959;1861:34-46.
7. Akiba T, Koyama T, Isshiki T, Kimura S, Fukushima T. On the mechanism of the development of multiple-drug-resistant clones of Shigella. Jpn J Microbiol. 1960;4:219-227
8. Tauxe RV, Cavanagh TR, Cohen ML. Interspecies gene transfer in vivo producing an outbreak of multiple resistant shigellosis. J Infect Dis. 1989;160:1067-1070
9. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis. 2002;34:482-492 (Pubitemid 34112269)
10. Ojo KK, Ulep C, Van Kirk N, Luis H, Bernardo M, Leitao J, et al. The mef(A) gene predominates among seven macrolide resistance genes identified in gram-negative strains representing 13 genera, isolated from healthy Portuguese children. Antimicrob Agents Chemother. 2004;48:3451-3456 DOI: 10.1128/AAC.48.9.3451-3456.2004
11. Arthur M, Andremont A, Courvalin P. Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin. Antimicrob Agents Chemother. 1987;31:404-409
12. O'Hara K, Kanda T, Ohmiya K, Ebisu T, Kono M. Purification and characterization of macrolide 2'-phosphotransferase from a strain of Escherichia coli that is highly resistant to erythromycin. Antimicrob Agents Chemother. 1989;33:1354-1357